In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin

Mater Sci Eng C Mater Biol Appl. 2019 Sep:102:96-105. doi: 10.1016/j.msec.2019.04.033. Epub 2019 Apr 13.

Abstract

In this article, we have reported the inclusion complex behaviors and their pharmaceutical application of anticancer drug property of Etoposide with β-cyclodextrin. The inclusion complex is used to improve the poor aqueous solubility of the anticancer drug Etoposide. The aqueous solubility and in-vitro dissolution studies support to the anticancer drug Etoposide with β-cyclodextrin complex is significantly improves the aqueous solubility. Etoposide:β-cyclodextrin solid-state complexes were prepared by Physical mixture, kneading and solvent evaporation methods, and were characterized by FT-IR, 1HNMR, XRD, DSC and SEM techniques. In addition, the in-vitro antimicrobial and antibiofilm study of Etoposide drug is a sensible microorganism was significantly increased by an inclusion complexation process. The antibiofilm of anticancer drug Etoposide with β-cyclodextrin studies have been analyzed by confocal laser scanning microscopy.

Keywords: Antimicrobial efficacy; Dissolution rate; Etoposide; Phase solubility; β-Cyclodextrin.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Bacillus licheniformis / drug effects
  • Bacteria / drug effects*
  • Bacteria / ultrastructure
  • Biofilms / drug effects
  • Calorimetry, Differential Scanning
  • Etoposide / pharmacology*
  • Microbial Sensitivity Tests
  • Proton Magnetic Resonance Spectroscopy
  • Solubility
  • Spectroscopy, Fourier Transform Infrared
  • Vibrio parahaemolyticus / drug effects
  • X-Ray Diffraction
  • beta-Cyclodextrins / pharmacology*

Substances

  • Antineoplastic Agents
  • beta-Cyclodextrins
  • Etoposide
  • betadex